|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | |
| C07D 519/00 |
| (11) | Patento numeris | 2332940 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10182365.6 |
| Europos patento paraiškos padavimo data | 2005-03-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-06-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-10-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 557503 P | 2004-03-30 | US | |
| 625599 P | 2004-11-05 | US |
| (72) |
Salituro, Francesco, US
Farmer, Luc, US
Bethiel, Randy, US
Harrington, Edmund, US
Green, Jeremy, US
Court, John, US
Come, Jon, US
Lauffer, David, US
Aronov, Alex, US
Binch, Hayley, GB
Boyall, Dean, GB
Charrier, Jean-Damien, GB
Everitt, Simon, GB
Fraysse, Damien, GB
Mortimore, Michael, GB
Pierard, Franēoise, GB
Robinson, Daniel, GB
Pinder, Joanne, GB
Wang, Tiansheng, US
Pierce, Albert, US
Wang, Jian, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
130 Waverly Street, Cambridge, MA 02139,
US
|
| (54) | Azaindoles useful as inhibitors of JAK and other protein kinases |
| Azaindoles useful as inhibitors of JAK and other protein kinases |